Vaxil Bio Ltd (VXLLF)
0.0051
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Vaxil Bio Total Assets (Quarterly): 0.7357M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7357M |
| September 30, 2023 | 0.7725M |
| June 30, 2023 | 0.8459M |
| March 31, 2023 | 1.008M |
| December 31, 2022 | 1.135M |
| September 30, 2022 | 1.257M |
| June 30, 2022 | 1.465M |
| March 31, 2022 | 1.594M |
| December 31, 2021 | 1.792M |
| September 30, 2021 | 1.874M |
| June 30, 2021 | 2.177M |
| March 31, 2021 | 2.415M |
| December 31, 2020 | 1.303M |
| September 30, 2020 | 0.6544M |
| June 30, 2020 | 0.8508M |
| March 31, 2020 | 0.8885M |
| December 31, 2019 | 0.1569M |
| September 30, 2019 | 0.1987M |
| June 30, 2019 | 0.3253M |
| March 31, 2019 | 0.4846M |
| December 31, 2018 | 0.6534M |
| September 30, 2018 | 0.8947M |
| June 30, 2018 | 1.037M |
| March 31, 2018 | 1.168M |
| December 31, 2017 | 0.2465M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.2106M |
| June 30, 2017 | 0.4698M |
| March 31, 2017 | 0.7071M |
| December 31, 2016 | 0.9026M |
| September 30, 2016 | 1.010M |
| June 30, 2016 | 1.253M |
| March 31, 2016 | 1.488M |
| November 30, 2015 | 0.0115M |
| August 31, 2015 | 0.0321M |
| May 31, 2015 | 0.0932M |
| February 28, 2015 | 0.3331M |
| November 30, 2014 | 0.1959M |
| August 31, 2014 | 0.2081M |
| May 31, 2014 | 0.2333M |
| February 28, 2014 | 0.2686M |
| November 30, 2013 | 0.3643M |
| August 31, 2013 | 0.5608M |
| May 31, 2013 | 0.2631M |
| February 28, 2013 | 0.2902M |
| November 30, 2012 | 0.3476M |
| August 31, 2012 | 0.3503M |
| May 31, 2012 | 0.3525M |
| February 29, 2012 | 0.3231M |
| November 30, 2011 | 0.3218M |
| August 31, 2011 | 0.4568M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.1569M
Minimum
Dec 2019
2.415M
Maximum
Mar 2021
1.129M
Average
1.008M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.0641M |
| Shareholders Equity (Quarterly) | 0.6716M |